1- ((N- (2,3,4,5,6- pentafluorocinnamoyl)- O- (2,6- dichlorobenzyl))tyrosyl)- 4- (bis(diethoxyphosphono))methylaminiopiperidine
a survivin inhibitor that inhibits bone metastatic growth of prostate cancer cells; structure in first source
Also Known As:
BKM 1740; BKM-1740; BKM1740
Networked: 1
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Chung, Leland W K:
1 article
(10/2008)
|
2. | Gera, Lajos:
1 article
(10/2008)
|
3. | Iqbal, Shareen:
1 article
(10/2008)
|
4. | Johnson, Nicole A:
1 article
(10/2008)
|
5. | Qian, Wei Ping:
1 article
(10/2008)
|
6. | Seo, Seong Il:
1 article
(10/2008)
|
7. | Stewart, John:
1 article
(10/2008)
|
8. | Wang, Ruoxiang:
1 article
(10/2008)
|
9. | Wu, Daqing:
1 article
(10/2008)
|
10. | Zayzafoon, Majd:
1 article
(10/2008)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures